More Foreign Corrupt Practices Act (FCPA) Articles

Healthcare

Fourth Circuit Denies False Claims Act Liability For Regulatory Violations Related To Pharmaceutical Manufacturing

Last month, the United States Court of Appeals for the Fourth Circuit affirmed the district court’s dismissal of a False Claims Act (“FCA”) suit against Omnicare, Inc. and related entities in relation to Medicaid and Medicare reimbursement of drugs that the relator alleged were...

Read More

Anti-Corruption

SEC And DOJ Officials Discuss Foreign Corrupt Practices Act Enforcement Trends And Priorities

On November 19 and 20, 2013, the American Conference Institute held the 30th annual U.S. Foreign Corrupt Practices Act (FCPA) conference outside of Washington, DC. Keynote addresses were given by U.S. Department of Justice (DOJ) Deputy Attorney General James Cole and U.S. Securities Exchange...

Read More

Anti-Corruption

Forensic Experts Discuss Key FCPA Issues And Compliance Strategies For The Real World

Editor: How are companies responding to increased global regulatory coordination and sophistication with regard to anti-bribery and corruption (“ABC”) enforcement efforts? deGrasse: The government’s enforcement efforts certainly have become more sophisticated. The DoJ and SEC...

Read More